Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Addiction Neuroscience|January 1, 2026
Sex-specific transcriptional signatures of oxycodone persist during withdrawal and abstinence in the suprachiasmatic nucleus of heterogeneous stock ratsTara C Delorme, Snehal Sambare, Benjamin R Williams, et al.
Emerging Infectious Diseases|November 25, 2014
Human metapneumovirus infection in chimpanzees, United StatesOwen M Slater, Karen A Terio, Yange Zhang, et al.
Drug and Alcohol Dependence|April 21, 2026
Impact of a stimulant-inclusive post-overdose outreach toolkit on engagement of overdose survivors who use stimulants: An interrupted time series analysisZiming Xuan, Alexander Y Walley, Scott W Formica, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Integrative multi-dimensional characterization of striatal projection neuron heterogeneity in adult brainJenesis Gayden, Stephanie Puig, Chaitanya Srinivasan, et al.
Open Forum Infectious Diseases|July 20, 2022
Supratherapeutic Tacrolimus Concentrations With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients Requiring Hospitalization: A Case Series Using Rifampin for ReversalDusten T Rose, Saurin M Gandhi, Rachael A Bedard, et al.
International Journal of Molecular Sciences|August 14, 2025
Identification of Drug Repurposing Candidates for Coxsackievirus B3 Infection in iPSC-Derived Brain-like Endothelial CellsJacob F Wood, John M Vergis, Ali S Imami, et al.
Neurorehabilitation|January 30, 2014
The effects of speed-dependent treadmill training and rhythmic auditory-cued overground walking on balance function, fall incidence, and quality of life in individuals with idiopathic Parkinson's disease: a randomized controlled trialC C Harro, M J Shoemaker, O Frey, et al.
Health Technology Assessment (Winchester, England)|October 2, 2007
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trialA G Marson, R Appleton, G A Baker, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cellsGreg N Brooke, Simon C Gamble, Michael A Hough, et al.
Trials|June 20, 2020
Understanding and optimising patient and public involvement in trial oversight: an ethnographic study of eight clinical trialsK D Coulman, A Nicholson, A Shaw, et al.
Pageof 20